Bluelinea Société Anonyme

ENXTPA:ALBLU Stock Report

Market Cap: €12.3m

Bluelinea Société Anonyme Past Earnings Performance

Past criteria checks 0/6

Bluelinea Société Anonyme has been growing earnings at an average annual rate of 8.2%, while the Medical Equipment industry saw earnings growing at 10.8% annually. Revenues have been growing at an average rate of 10.3% per year.

Key information

8.2%

Earnings growth rate

83.7%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate10.3%
Return on equity-37.7%
Net Margin-16.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Bluelinea Société Anonyme (EPA:ALBLU) Is Carrying A Fair Bit Of Debt

Dec 14
Bluelinea Société Anonyme (EPA:ALBLU) Is Carrying A Fair Bit Of Debt

Revenue & Expenses Breakdown

How Bluelinea Société Anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALBLU Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2310-200
31 Dec 2211-260
30 Sep 2211-260
30 Jun 2210-260
31 Mar 229-350
31 Dec 218-350
30 Sep 218-340
30 Jun 218-350
31 Mar 217-350
31 Dec 207-350
30 Sep 207-360
30 Jun 207-350
31 Mar 207-340
31 Dec 197-340
30 Sep 197-340
30 Jun 197-350
31 Mar 197-350
31 Dec 187-350
30 Sep 187-340
30 Jun 187-250
31 Mar 187-350
31 Dec 177-350
30 Sep 177-350
30 Jun 176-550
31 Mar 176-550
31 Dec 167-350
30 Sep 167-250
30 Jun 167-250
31 Mar 167-150
31 Dec 157-150
30 Sep 157-141
30 Jun 156-240
31 Mar 155-240
31 Dec 145-240
31 Dec 133-120

Quality Earnings: ALBLU is currently unprofitable.

Growing Profit Margin: ALBLU is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALBLU is unprofitable, but has reduced losses over the past 5 years at a rate of 8.2% per year.

Accelerating Growth: Unable to compare ALBLU's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALBLU is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.9%).


Return on Equity

High ROE: ALBLU has a negative Return on Equity (-37.67%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.